189 related articles for article (PubMed ID: 2070069)
21. Long-term expression of retroviral-transduced adenosine deaminase in human primitive hematopoietic progenitors.
Mitani K; Wakamiya M; Caskey CT
Hum Gene Ther; 1993 Feb; 4(1):9-16. PubMed ID: 8461384
[TBL] [Abstract][Full Text] [Related]
22. Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice.
Dao MA; Yu XJ; Nolta JA
Exp Hematol; 1997 Dec; 25(13):1357-66. PubMed ID: 9406995
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.
Moore KA; Scarpa M; Kooyer S; Utter A; Caskey CT; Belmont JW
Hum Gene Ther; 1991; 2(4):307-15. PubMed ID: 1838933
[TBL] [Abstract][Full Text] [Related]
24. Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo.
Kaptein LC; Breuer M; Valerio D; van Beusechem VW
Gene Ther; 1998 Mar; 5(3):320-30. PubMed ID: 9614551
[TBL] [Abstract][Full Text] [Related]
25. Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: the effect of viral titers on transduction efficiency.
Van Beusechem VW; Bakx TA; Kaptein LC; Bart-Baumeister JA; Kukler A; Braakman E; Valerio D
Hum Gene Ther; 1993 Jun; 4(3):239-47. PubMed ID: 8338872
[TBL] [Abstract][Full Text] [Related]
26. The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells.
Chertkov JL; Jiang S; Lutton JD; Harrison J; Levere RD; Tiefenthaler M; Abraham NG
Stem Cells; 1993 May; 11(3):218-27. PubMed ID: 8318909
[TBL] [Abstract][Full Text] [Related]
27. Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease.
Moritz T; Keller DC; Williams DA
J Exp Med; 1993 Aug; 178(2):529-36. PubMed ID: 8340757
[TBL] [Abstract][Full Text] [Related]
28. Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses.
van Beusechem VW; Kukler A; Einerhand MP; Bakx TA; van der Eb AJ; van Bekkum DW; Valerio D
J Exp Med; 1990 Sep; 172(3):729-36. PubMed ID: 1974914
[TBL] [Abstract][Full Text] [Related]
29. Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells.
Cournoyer D; Scarpa M; Mitani K; Moore KA; Markowitz D; Bank A; Belmont JW; Caskey CT
Hum Gene Ther; 1991; 2(3):203-13. PubMed ID: 1751590
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow gene therapy for adenosine deaminase deficiency.
Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
[TBL] [Abstract][Full Text] [Related]
31. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.
Hawley RG; Hawley TS; Fong AZ; Quinto C; Collins M; Leonard JP; Goldman SJ
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10297-302. PubMed ID: 8816794
[TBL] [Abstract][Full Text] [Related]
32. Expression of human adenosine deaminase in murine hematopoietic cells.
Belmont JW; MacGregor GR; Wager-Smith K; Fletcher FA; Moore KA; Hawkins D; Villalon D; Chang SM; Caskey CT
Mol Cell Biol; 1988 Dec; 8(12):5116-25. PubMed ID: 3072474
[TBL] [Abstract][Full Text] [Related]
33. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
[TBL] [Abstract][Full Text] [Related]
34. Development of improved adenosine deaminase retroviral vectors.
Onodera M; Nelson DM; Yachie A; Jagadeesh GJ; Bunnell BA; Morgan RA; Blaese RM
J Virol; 1998 Mar; 72(3):1769-74. PubMed ID: 9499026
[TBL] [Abstract][Full Text] [Related]
35. Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo.
Williams DA; Orkin SH; Mulligan RC
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2566-70. PubMed ID: 3458218
[TBL] [Abstract][Full Text] [Related]
36. Recombinant adeno-associated virus-mediated gene transfer for the potential therapy of adenosine deaminase-deficient severe combined immune deficiency.
Silver JN; Elder M; Conlon T; Cruz P; Wright AJ; Srivastava A; Flotte TR
Hum Gene Ther; 2011 Aug; 22(8):935-49. PubMed ID: 21142972
[TBL] [Abstract][Full Text] [Related]
37. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells.
Nolta JA; Smogorzewska EM; Kohn DB
Blood; 1995 Jul; 86(1):101-10. PubMed ID: 7795215
[TBL] [Abstract][Full Text] [Related]
38. Protection of uninfected human bone marrow cells in long-term culture from G418 toxicity after retroviral-mediated transfer of the NEOr gene.
Bayever E; Haines K; Duprey S; Rappaport E; Douglas SD; Surrey S
Exp Cell Res; 1988 Nov; 179(1):168-80. PubMed ID: 2844566
[TBL] [Abstract][Full Text] [Related]
39. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
Belmont JW; Henkel-Tigges J; Chang SM; Wager-Smith K; Kellems RE; Dick JE; Magli MC; Phillips RA; Bernstein A; Caskey CT
Nature; 1986 Jul 24-30; 322(6077):385-7. PubMed ID: 3016551
[TBL] [Abstract][Full Text] [Related]
40. Introduction of sequences encoding functional human adenosine deaminase into mouse cells using a retroviral shuttle system.
Valerio D; Duyvesteyn MG; van der Eb AJ
Gene; 1985; 34(2-3):163-8. PubMed ID: 4007492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]